Tradestie Institutional Equity Comparison Engine

XOMA vs LGND โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

XOMA Overall Edge

XOMA Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to XOMA Royalty Corporation Common Stock (XOMA) driven by superior Valuation, Growth & Margin while LGND counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, XOMA trades at 21.5x Forward P/E with -3.9% operating margin (-22.6% YoY revenue) versus LGND at 25.8x Forward P/E and 14.4% operating margin (-31.8% YoY). In options structure, XOMA sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against LGND sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner XOMA
XOMA 21.5x vs LGND 25.8x Fwd P/E
Growth & Margin Winner XOMA
Op Margin -3.9% vs 14.4% ยท YoY -22.6% vs -31.8%
Momentum & Technical Winner LGND
1Y +44.0% vs +51.5% ยท 52W Pos 78% vs 86%
Options & Structure Winner LGND
UNCLASSIFIED (100th %ile IV) vs CONSOLIDATION (8th %ile IV)
XOMA NASDAQ
XOMA Royalty Corporation Common Stock
Pharmaceutical Preparations
$40.17
-9.16% 1D
Market Cap $781.8M
1M Return -3.81%
1Y Return +43.98%
Forward P/E 21.5x
Unified AI Score
55.8 / 100 HOLD
Tech 40.0 Fund 52.0 Flow 50.0 Mom 64.0
LGND NASDAQ
Ligand Pharmaceuticals Inc.
Pharmaceutical Preparations
$304.93
-1.25% 1D
Market Cap $6.3B
1M Return +3.18%
1Y Return +51.5%
Forward P/E 25.8x
Unified AI Score
42.6 / 100 HOLD
Tech 44.0 Fund 47.0 Flow 63.0 Mom 31.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: XOMA +43.98% LGND +51.5% Spread: +29.05 pp (LGND Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
XOMA TTM Op. Margin: -3.9% LGND TTM Op. Margin: 14.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XOMA vs LGND. Trailing 12-month operating profitability (XOMA -3.9% vs LGND 14.4%) and valuation multiples (XOMA 21.5x vs LGND 25.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: XOMA (7) vs LGND (3)
Institutional Metric XOMA LGND Criterion Row Winner
Market Capitalization Scale $781.8M $6.3B Larger Scale LGND
Trailing P/E Ratio Valuation 28.2x 127.0x Lower Multiple XOMA
Forward P/E Ratio Valuation 21.5x 25.8x Lower Multiple XOMA
Revenue Growth (YoY) Growth -22.6% -31.8% Higher Growth XOMA
Operating Margin (TTM) Profitability -3.9% 14.4% Higher Margin LGND
Net Profit Margin Profitability 69.6% 20.3% Higher Margin XOMA
Return on Equity (ROE) Capital Efficiency 34.2% 5.4% Higher ROE XOMA
52-Week Range Position Momentum 78% ($22โ€“$45) 86% ($176โ€“$327) Stronger Trend LGND
Beta / 30D Volatility Risk Regime 0.68ฮฒ ยท 37% Vol 0.99ฮฒ ยท 38% Vol Lower Realized Risk XOMA
Unified Institutional Score Composite Signal 55.8 / 100 (HOLD) 42.6 / 100 (HOLD) Higher Composite XOMA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full XOMA vs LGND Buy Guide
XOMA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live XOMA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LGND CONSOLIDATION
98d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live LGND Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither XOMA nor LGND registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.